Immuneering Corporation (IMRX)
NASDAQ: IMRX
· Real-Time Price · USD
3.79
0.75 (24.67%)
At close: Aug 15, 2025, 3:59 PM
3.65
-3.57%
After-hours: Aug 15, 2025, 07:49 PM EDT
Immuneering Ratios and Metrics
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
PE Ratio | -0.9 | -0.95 | -1.27 | -0.62 | -1.41 | -3.57 | -4.46 | -5.96 | 0.06 | -2.56 | -7.56 | -3.1 | -3.31 | -9.74 | -14.22 | -13.15 | -9.54 |
PEG Ratio | 0.03 | -0.05 | -0.3 | 0.15 | 0.24 | -0.17 | n/a | 0.06 | -0.00 | n/a | -1.11 | 0.30 | -0.2 | 0.92 | -0.34 | 0.47 | -1.37 |
PS Ratio | n/a | n/a | n/a | n/a | n/a | -2.28 | n/a | 3.08 | n/a | 280.86K | 9.85K | 1.51K | 928.39 | 2.22K | 1.01K | 636.65 | 317.65 |
PB Ratio | 1.29 | 1.65 | 1.29 | 0.52 | 1.03 | 2.38 | 2.16 | 2.52 | 2.63 | 1.17 | 3.10 | 1.07 | 1.18 | 2.69 | 3.07 | -11.94 | 8.04 |
P/FCF Ratio | -3.83 | -4.7 | -5.51 | -3 | -5.2 | -18.01 | -18.6 | -26.81 | -17.77 | -10.84 | -34.31 | -14.85 | -13.76 | -45.4 | -53.67 | -65.08 | -38.6 |
P/OCF Ratio | -3.84 | -4.71 | -5.52 | -3.01 | -5.21 | -18.27 | -18.69 | -27.03 | -17.81 | -10.9 | -35.58 | -15.11 | -13.89 | -45.47 | -53.74 | -65.28 | -38.71 |
OCF/S Ratio | n/a | n/a | n/a | n/a | n/a | 0.12 | n/a | -0.11 | n/a | -25.76K | -276.77 | -100.08 | -66.85 | -48.73 | -18.74 | -9.75 | -8.21 |
Debt / Equity Ratio | 0.10 | 0.10 | 0.07 | 0.07 | 0.06 | 0.05 | 0.04 | 0.04 | 0.05 | 0.04 | 0.04 | 0.04 | 0.03 | 0.03 | 0.00 | -0.02 | 0.02 |
Quick Ratio | 7.48 | 5.28 | 7.99 | 9.39 | 14.38 | 11.35 | 17.89 | 20.35 | 17.05 | 13.50 | 16.54 | 33.99 | 37.98 | 27.04 | 29.11 | 10.65 | 11.67 |
Current Ratio | 7.48 | 5.28 | 7.99 | 9.39 | 14.38 | 11.35 | 17.89 | 20.35 | 17.05 | 13.50 | 16.54 | 33.99 | 37.98 | 27.04 | 29.11 | 10.65 | 11.67 |
Asset Turnover | n/a | n/a | n/a | n/a | n/a | -0.92 | n/a | 0.76 | n/a | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 | 0.02 |
Interest Coverage | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Return on Equity | -0.36 | -0.44 | -0.25 | -0.21 | -0.18 | -0.17 | -0.12 | -0.11 | 10.86 | -0.11 | -0.1 | -0.09 | -0.09 | -0.07 | -0.05 | 0.23 | -0.21 |
Return on Assets | -0.3 | -0.34 | -0.21 | -0.18 | -0.16 | -0.15 | -0.11 | -0.1 | 9.86 | -0.1 | -0.09 | -0.08 | -0.08 | -0.06 | -0.05 | -0.15 | -0.19 |
Return on Invested Capital | -0.34 | -0.41 | -0.25 | -0.21 | -0.18 | -0.16 | -0.13 | -0.1 | 11.17 | -0.12 | -0.1 | -0.08 | -0.09 | -0.07 | -0.05 | -0.17 | -0.21 |
Dividend Yield | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit Margin | n/a | n/a | n/a | n/a | n/a | 1.00 | n/a | 1.00 | n/a | -346.41K | 0.50 | 0.49 | 0.51 | -0.09 | 0.55 | 0.52 | 0.45 |
Net Profit Margin | n/a | n/a | n/a | n/a | n/a | 0.16 | n/a | -0.13 | n/a | -27.42K | -325.7 | -122.09 | -70.04 | -56.88 | -17.7 | -12.1 | -8.33 |
Pretax Profit Margin | n/a | n/a | n/a | n/a | n/a | 0.16 | n/a | -0.13 | n/a | -29.05K | -334.66 | -122.09 | -70.2 | -58.5 | -17.7 | -12.1 | -8.33 |
Operating Profit Margin | n/a | n/a | n/a | n/a | n/a | 0.17 | n/a | -0.14 | n/a | -30.67K | -343.62 | -123.34 | -70.36 | -58.63 | -17.72 | -12.11 | -8.33 |
FCF Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
EBITDA Margin | n/a | n/a | n/a | n/a | n/a | 0.16 | n/a | -0.14 | n/a | -30.48K | -341.66 | -122.69 | -69.11 | -58.23 | -17.62 | -12.05 | -8.28 |